Yew Bio Pharm Balance Sheet - Annual (OTCMKTS:YEWB)

Add to My Stocks
$0.2 $0 (0%) YEWB stock closing price Aug 18, 2017 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Yew Bio Pharm stock analysis. As in our Yew Bio Pharm stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. A company releases its balance sheet every quarter along with its quarterly results. Yew Bio Pharm revenue was $51.34M and Yew Bio Pharm operating cash flow was $0.64M for 2016. The balance sheet shows total liabilities of $7.61M and shareholders equity of $38.57M. View latest and last 10 year balance sheet data to check Yew Bio Pharm financial performance..

show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec.201620152014201320122011
Marketable Securities------
Raw Materials5.06M3.33M1.44M0.87M0.81M0.45M
Work In Progress---0.01M0.02M0.01M
Finished Goods5.24M1.33M-0.19M0.15M0.23M
Notes Receivable------
Other Current Assets0.15M0.17M0.02M0.03M0.06M-
Yew Bio Pharm Total Current Assets
Property Plant & Equipment1.77M1.74M1.89M2.01M1.66M1.39M
Accumulated Depreciation1.08M1.04M1.03M0.98M0.77M0.61M
Yew Bio Pharm Net Property Plant & Equipment
Investment & Advances------
Other Non-Current Assets------
Deferred Charges------
Deposits & Other Assets7.15M12.33M10.66M10.24M9.38M7.5M
Yew Bio Pharm Total Assets
Notes Payable1.15M0.6M----
Accounts Payable3.33M0.05M---1.36M
Current Portion Long-Term Debt2.6M3.84M0.04M4.85M0.04M0.26M
Current Portion Capital Leases------
Accrued Expenses0.37M0.12M0.08M0.13M0.19M0.11M
Income Taxes Payable0.01M0.01M0.01M0.01M0.01M-
Other Current Liabilities-----0.95M
Yew Bio Pharm Total Current Liabilities
Deferred Taxes/Income0.12M-----
Convertible Debt------
Long-Term Debt------
Non-Current Capital Leases------
Other Long-Term Liabilities------
Yew Bio Pharm Total Liabilities
Minority Interest------
Preferred Stock------
Common Stock Net0.05M0.05M0.05M0.05M0.05M0.04M
Capital Surplus9.65M9.62M8.55M8.05M10.39M7.2M
Retained Earnings27.07M25.06M20.44M16.66M13.18M11.46M
Treasury Stock------
Other Liabilities1.79M4.42M5.84M5.54M4.16M3.48M
Yew Bio Pharm Shareholders Equity
Yew Bio Pharm Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Balance sheet for another ticker

Most investors just check the Yew Bio Pharm stock price, and Yew Bio Pharm historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Yew Bio Pharm PE ratio chart. Below is a brief explanation of common balance sheet terms:
  • Assets: An asset is a resource that a corporation like Yew Bio Pharm owns and has monetary significance. YEWB assets grew from $43.81M in 2015 to $46.19M in 2016 . Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. YEWB stock had total liabilities of $7.61M for year 2016.

Yew Bio Pharm Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio
Asset Turnover
receivables turnover
PB ratio (
price to book ratio